An $872 Million Week for Philly Biotech Companies
August 9, 2017
Drexel and Context Therapeutics were mentioned in an Aug. 9 Philadelphia Inquirer story about Philadelphia biotech firms attracting out-of-town investment and acquisition capital. Context is a Drexel spin-off co-founded by Felix Kim, PhD, an assistant professor in the College of Medicine.
Related:
Drexel News is produced by
University Marketing and Communications.